CONSORZIO ONCOTECH
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- -
- Market Cap
- -
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2016-06-15
- Lead Sponsor
- Consorzio Oncotech
- Target Recruit Count
- 61
- Registration Number
- NCT02175446
- Locations
- 🇮🇹
Istituto Regina Elena per lo studio e la cura dei tumori, Roma, Italy
🇮🇹I.R.C.C.S. A.O.U. San Martino - I.S.T., Genova, Italy
🇮🇹Azienda Ospedaliera Universitaria Pisana - Ospedale S. Chiara, Pisa, Italy
FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC
- First Posted Date
- 2008-09-12
- Last Posted Date
- 2014-12-17
- Lead Sponsor
- Consorzio Oncotech
- Target Recruit Count
- 47
- Registration Number
- NCT00751868
- Locations
- 🇮🇹
Azienza Osped.Treviglio - Caravaggio, Treviglio, BG, Italy
🇮🇹Ospedale Civile di Campobasso - A. Cardarelli, Campabasso, CB, Italy
🇮🇹Università Federico II, Napoli, Italy
© Copyright 2024. All Rights Reserved by MedPath